Viventia Bio Inc.

Canada

 
Total IP 24
Total IP Rank # 60,806
IP Activity Score 0.9/5.0    2
IP Activity Rank # 467,433
Dominant Nice Class Pharmaceutical, veterinary and s...

Patents

Trademarks

13 0
3 1
7 0
0
 
Last Patent 2018 - Methods of treatment for epcam p...
First Patent 1994 - Human monoclonal antibodies spec...
Last Trademark 2000 - VIVENTIA
First Trademark 2000 - VIVENTIA

Industry (Nice Classification)

Latest Inventions, Goods, Services

2016 Invention Methods for making and using an immunoconjugate for the treatment of cancer. The present inventio...
Invention Her2 immunotoxins and methods of using the same. The present invention relates to methods for pre...
Invention Deimmunized linker and methods of use. The present disclosure is directed to novel deimmunized fu...
Invention Methods of treatment for epcam positive bladder cancer. The present disclosure provides compositi...
Invention Dosing strategies for targeting epcam positive bladder cancer. The present disclosure provides me...
2015 Invention Tumor specific antibody. The present invention provides the amino acid and nucleic acid sequence...
2014 Invention Cancer-associated antigen related applications. The present invention provides a novel cancer-as...
Invention Anti-epcam antibodies and methods of use. The present disclosure is related to compositions of an...
Invention Compositions and methods for detection and treatment of hepatocellular carcinoma. Disclosed here...
Invention Compositions and methods for detection and treatment of hepatocellular carcinoma. Disclosed herei...
2013 Invention Antibody conjugates against variant nfkbib and uses thereof. The present application provides the...
Invention Cancer-associated antigen. The present invention provides a novel cancer-associated antigen that ...
Invention Tumor specific antibody. The present invention provides the amino acid and nucleic acid sequences...
2012 Invention Antibodies against a cancer-associated epitope of variant hnrnpg and uses thereof. The present a...
2011 Invention Cancer specific antibody and cell surface proteins. The present invention provides the amino acid...
2008 Invention Antibodies against a cancer-associated epitope of variant nfkbib and uses thereof. The present ap...
Invention Antibodies against a cancer-associated epitope of variant hnrnpg and uses thereof. The present ap...
Invention Optimized nucleic acid sequences for the expression of vb4-845. Escherichia coli expression system.
Invention Binding proteins that bind to epcam linked to an effector molecule. E. coli expression system.
Invention Optimized nucleotide sequences of vb6-845 for expression of recombinant proteins. An optimized nu...
2006 Invention Methods for generating and screening fusion protein libraries and uses thereof. The invention pro...
Invention Novel cancer-associated antigen. The present invention provides a novel cancer-associated antigen...
2005 Invention Cancer associated glucose transporter 8 variant. The present invention provides the amino acid an...
Invention Cd44e tumor specific antibody. The present invention provides the amino acid and nucleic acid seq...
2000 G/S Polypeptides for use in the biopharmaceutical industry; biopharmaceutical preparations for immuno...
1999 Invention Antigen binding fragments that specifically detect cancer cells, nucleotides encoding the fragmen...
1994 Invention Human monoclonal antibodies specific to cell cycle independent glioma surface antigen. The variab...